20.500.12592/swq366
CADTH Reimbursement Review - Upadacitinib (Rinvoq) - Sponsor: AbbVie Corporation Therapeutic area: Ankylosing spondylitis
25 August 2023
Summary
Stakeholder Input
Pages
238
Published in
Canada
Creators/Authors
83 results found
